136
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Multiplication of neutrophil and monocyte counts (MNM) as an easily obtainable tumour marker for cervical cancer

&
Pages 161-170 | Received 19 Nov 2008, Accepted 26 Jan 2009, Published online: 01 May 2009

References

  • Abe A, Nakano T, Morita S, Oka K. 1999. Clinical evaluation of serum and immunohistochemical expression of SCC and CA19-9 in radiation therapy for cervical cancer. Anticancer Res 19:829–836.
  • Adam RA, Horowitz IR, Tekmal RR. 1999. Serum levels of macrophage colony-stimulating factor-1 in cervical human papillomavirus infection and intraepithelial neoplasia. Am J Obstet Gynecol 180:28–32.
  • Avall-Lundqvist EH, Sjovall K, Nilsson BR, Eneroth PH. 1992. Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma. Eur J Cancer 28A:1695–1702.
  • Balkwill F, Mantovani A. 2001. Inflammation and cancer: back to Virchow? Lancet 357:539–545.
  • Bolger BS, Dabbas M, Lopes A, Monaghan JM. 1997. Prognostic value of preoperative squamous cell carcinoma antigen level in patients surgically treated for cervical carcinoma. Gynecol Oncol 65:309–313.
  • Bosch FX, Munoz N. 2002. The viral etiology of cervical cancer. Virus Res 89:183–190.
  • Brower V. 2005. Feeding the flame: new research adds to role of inflammation in cancer development. J Natl Cancer Inst 97:251–253.
  • Cho H, Hur HW, Kim SW, Kim SH, Kim JH, Kim YT, Lee K. 2009. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother 58:15–23.
  • Chou CY, Wang ST, Kuo HC, Tzeng CC, Yao BL. 1994. Serum level of squamous cell carcinoma antigen and tumor size are useful to identify preoperatively patients at high risk of cervical cancer. Cancer 74:2497–2501.
  • Da Silva DM, Fausch SC, Verbeek JS, Kast WM. 2007. Uptake of human papillomavirus virus-like particles by dendritic cells is mediated by Fcgamma receptors and contributes to acquisition of T cell immunity. J Immunol 178:7587–7597.
  • Duk JM, Groenier KH, de Bruijn HW, Hollema H, ten Hoor KA, van der Zee AG, Aalders JG. 1996. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma. J Clin Oncol 14:111–118.
  • Eiben GL, Velders MP, Kast WM. 2002. The cell-mediated immune response to human papillomavirus-induced cervical cancer: implications for immunotherapy. Adv Cancer Res 86:113–148.
  • Gustafsson L, Ponten J, Zack M, Adami HO. 1997. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 8:755–763.
  • Koutsky LA, Harper DM. 2006. Chapter 13: Current findings from prophylactic HPV vaccine trials. Vaccine 24(Suppl. 3):S114–121.
  • Kristensen GB, Abeler VM, Risberg B, Trop C, Bryne M. 1999. Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma. Gynecol Oncol 74:245–251.
  • Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH. 2003. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 6:283–287.
  • Massuger LF, Koper NP, Thomas CM, Dom KE, Schijf CP. 1997. Improvement of clinical staging in cervical cancer with serum squamous cell carcinoma antigen and CA 125 determinations. Gynecol Oncol 64:473–476.
  • Molina R, Filella X, Auge JM, Bosch E, Torne A, Pahisa J, Lejarcegui JA, Rovirosa A, Mellado B, Ordi J, Biete A. 2005. CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA. Anticancer Res 25:1765–1771.
  • Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J Clin 55:74–108.
  • Petignat P, Bouchardy C, Sauthier P. 2006. [Cervical cancer screening: current status and perspectives]. Rev Med Suisse 2:1308–1309, 1311–1302.
  • Punnonen R, Teisala K, Kuoppala T, Bennett B, Punnonen J. 1998. Cytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors. Cancer 83:788–796.
  • Schmidt H, Bastholt L, Geertsen P, Christensen IJ, Larsen S, Gehl J, von der Maase H. 2005. Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br J Cancer 93:273–278.
  • Singh N, Arif S. 2004. Histopathologic parameters of prognosis in cervical cancer – a review. Int J Gynecol Cancer 14:741–750.
  • Strauss HG, Laban C, Lautenschlager C, Buchmann J, Schneider I, Koelbl H. 2002. SCC antigen in the serum as an independent prognostic factor in operable squamous cell carcinoma of the cervix. Eur J Cancer 38:1987–1991.
  • Ueno H, Hawrylowicz CM, Banchereau J. 2007. Immunological intervention in human diseases. J Transl Med 5:59.
  • Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. 2005. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91:181–184.
  • Yuan CC, Wang PH, Ng HT, Tsai LC, Juang CM, Chiu LM. 2002. Both TPA and SCC-Ag levels are prognostic even in high-risk stage Ib-IIa cervical carcinoma as determined by a stratification analysis. Eur J Gynaecol Oncol 23:17–20.
  • Zahorec R. 2001. Ratio of neutrophil to lymphocyte counts–rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 102:5–14.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.